choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:

Avastin Newsletter
  • Biocon Biologics obtains FDA nod for Avastin biosimilar 10 Apr 2025 23:42 GMT

    … received the Food and Drug Administration’s green light … a biosimilar to Genentech’s Avastin (bevacizumab).  Jobevne is … stakeholders to bring more treatment options to patients." … more: Biocon Pharma gets FDA nod for norepinephrine bitartrate injection …

  • FDA Greenlights Bevacizumab Biosimilar Across Cancer Types 10 Apr 2025 22:49 GMT

    … Avastin) biosimilar, bevacizumab-nwgd (Jobevne), has been approved for the treatment … reference product. The FDA has granted approval to … immunogenicity. "The US FDA approval of [bevacizumab-nwgd … announces U.S. FDA approval for Jobevne™, biosimilar …

  • Bevacizumab Biosimilar Granted FDA Approval for Several Cancer Types 10 Apr 2025 22:47 GMT

    … FDA granted approval to bevacizumab-nwgd (Jobevne), a biosimilar for bevacizumab (Avastin … , affordable biologics.” Cancer Types and Treatment Lines Indicated The approval is … for the adjuvant, or postsurgical, treatment of colon cancer. About Bevacizumab …

  • Biocon Biologics secures USFDA approval for cancer treatment biosimilar 10 Apr 2025 22:11 GMT

    … United States Food and Drug Administration (USFDA) to … a biosimilar to the oncology drug Avastin (bevacizumab), for intravenous … the treatment of various forms of cancer. The drug … high-quality, affordable treatment options and strengthening our …

  • FDA Approves Biocon’s Avastin Biosimilar 10 Apr 2025 20:44 GMT

    The FDA has approved the fifth biosimilar of Genentech’s Avastin ( … efficacy, and immunogenicity. Related: Avastin Biosimilars Catching On For Patients … are an estimated 40 drugs in the bevacizumab biosimilars … AMD. The FDA set a Prescription Drug User Fee Act …

  • FDA Approves Avastin Biosimilar Jobevne Across Several Cancer Types 10 Apr 2025 20:04 GMT

    … Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin … treatment. Biosimilars, the FDA notes on its website, can increase access to lifesaving medications … is highly similar to Avastin, with no clinically meaningful differences …

  • FDA Approves Bevacizumab Biosimilar 10 Apr 2025 19:13 GMT

    … Biologics Ltd. announced that FDA has approved Jobevne™ ( … to the reference product Avastin® (bevacizumab). JOBEVNE is … stakeholders to bring more treatment options to patients.… special offers from American Pharmaceutical Review – all delivered …

  • FDA Greenlights Bevacizumab Biosimilar in Multiple Solid Tumor Indications 10 Apr 2025 19:28 GMT

    … )—a biosimilar referencing bevacizumab (Avastin)—for the treatment of patients with a … be withheld until hypertension is medically controlled and can be resumed … Biocon Biologics announces U.S. FDA approval for Jobevne, biosimilar bevacizumab …

  • Tempest seeks strategic alternatives as cash runs out for Phase 3 trial 10 Apr 2025 18:25 GMT

    … California-based biotechnology company prepares a liver cancer drug for late … as the drug being cleared for Phase 3 trials. Tempest ended … fully fund a Phase 3 trial. Brady said “the capital … and Avastin are one of two recommended first-line treatments for …

  • FDA Approves Biocon Biologics' Bevacizumab Biosimilar 10 Apr 2025 13:58 GMT

    … gaining FDA approval for Jobevne (bevacizumab-nwgd), the sixth biosimilar referencing Avastin … all stakeholders to bring more treatment options to patients," … Zirabev (bevacizumab-bvzr), Amneal Pharmaceuticals/;Kashiv Biosciences Alymsys (bevacizumab …

Satisfied with the content?

Continue to create your account.